PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for January 31, 2008 Subscribe to this News Feed    
 

Dr. Lycka and The Canadian Skin Cancer Foundation Give 70K to a Research Fund of the Cross Cancer Clinic

This gift helps to fund a chair in research and will go a long way in fighting melanoma skin cancer.

Edmonton, Canada (PRWEB) January 31, 2008 -- Dr. Barry Lycka, president of the Canadian Skin Cancer Foundation announced today a 70,000 gift to the Mary Johnston research chair in melanoma research today. This gift helps to fund a chair in research and according to Dr. Lycka, “Will go a long way in fighting the epidemic of melanoma skin cancer we are facing.”

“It’s sad that several hundred people die each year from this disease.”

According to Canadian Statistics, there will be 4500 new melanoma cases and 880 melanoma-related deaths in Canada this year, according to statistics from several cancer agencies. “It is our goal to make the number of those dieing drastically lower” Says Dr. Lycka.

For more information contact Dr. Barry Lycka at 780/425-1212.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/VGhpci1UaGlyLVpldGEtUGlnZy1aZXRhLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Dr. Barry Lycka
LesTout.com
780-425-1212
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move